$12.56
+0.00 (+0.00%)
Open$12.61
Previous Close$12.56
Day High$12.71
Day Low$12.42
52W High$17.65
52W Low$3.70
Volume—
Avg Volume1.58M
Market Cap956.80M
P/E Ratio11.10
EPS$0.94
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+418.9% upside
Current
$12.56
$12.56
Target
$65.17
$65.17
$47.12
$65.17 avg
$100.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 179.53M | 176.40M | 195.82M |
| Net Income | 39.25M | 28.13M | 36.61M |
| Profit Margin | 21.9% | 16.0% | 18.7% |
| EBITDA | 43.74M | 50.64M | 56.07M |
| Free Cash Flow | 39.04M | 39.72M | 27.68M |
| Rev Growth | -2.9% | +12.2% | +10.8% |
| Debt/Equity | 0.71 | 0.72 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |